1 (Image 1)
Chemical structure of the active ingredient Lubiprostone, showing its molecular framework including fluorine atoms and a carboxylic acid group.*
Lubiprostone Capsule, Gelatin Coated
Product Images NDC 0480-3479
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 0480-3479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
New (Image 2)
Lubiprostone Capsules 8 mcg gelatin coated oral capsules label from Teva Pharmaceuticals, Inc. The label states the total count of 60 capsules and includes directions to swallow whole without breaking or chewing. It also includes storage and safety instructions, dosage advice to refer to the package insert, and a barcode with the NDC 0480-3479-06.*
New (Image 3)
Label for Lubiprostone Capsules 24 mcg by Teva Pharmaceuticals, Inc. The label indicates the product is an oral gelatin-coated capsule with a quantity of 60 capsules. Instructions include swallowing whole without breaking, storing at 20 to 25°C, and protecting from extreme temperatures.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
